Moreover, CREBBP mutant lymphoma cells were also more sensitive to HDAC3i in a cell autonomous manner, which has led to the concept of using these drugs for precision therapy in FL and DLBCL. Here, CREBBP is linked to diffuse large B-cell lymphoma.